The hospital lobby is petitioning President Donald Trump to grant carve-outs for medical devices and pharmaceutical products ...

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger ...

A joint study conducted by UPM Raflatac and Corning Pharmaceutical Technologies has revealed the sustainability and ...

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company ...

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

Pharmacies in the UK face significant cuts, so it’s perhaps not surprising that they sell many unevidenced lifestyle products ...

Ligand Pharmaceuticals stock is on the rise with optimistic analyst ratings and a plan for 20% annual revenue growth. Learn ...

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

For too long, Big Pharma has filled the airwaves with tons of commercials to fuel demand for its products while failing to ...